Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: INSTITUT

Market Cap 4.4B 60.37M 52.08M 47.88M 45.07M 84.69M 5.7B 85.4M 567M 221M 2.8B 227M 222M 9.67B P/E 2024
25.7x
P/E 2025 46.2x
Enterprise Value 4.64B 63.59M 54.86M 50.44M 47.47M 89.2M 6B 89.95M 598M 233M 2.95B 239M 234M 10.19B EV / Sales 2024
3.02x
EV / Sales 2025 2.7x
Free-Float
17.07%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 68 23/08/2010
Director/Board Member 47 09/01/2014
Director/Board Member 45 01/01/2011
Change 5-day change 1-year change 3-year change Capi.($)
-1.55%+1.16%+47.80%+46.43% 129B
-2.21%+3.97%+4.22%+33.81% 88.05B
+0.70%+3.58%-9.23%+50.97% 25.34B
-1.63%-2.95%+10.51%+42.68% 22.25B
-1.96%-3.38%+0.04%+10.80% 21.71B
-0.32%+1.58%-11.02%-20.84% 20.4B
-2.76%+8.33%+6.59%+127.59% 15.81B
-2.82%+1.91%-6.68%-0.33% 14.71B
+0.77%+6.06%+54.26%+115.71% 13.42B
Average -1.31%+2.27%+10.72%+45.20% 38.91B
Weighted average by Cap. -1.53%+2.07%+20.06%+41.57%

Financials

2024 2025
Net sales 1.52B 20.87M 18.01M 16.55M 15.58M 29.28M 1.97B 29.52M 196M 76.37M 967M 78.33M 76.66M 3.34B 1.72B 23.54M 20.31M 18.67M 17.57M 33.02M 2.22B 33.3M 221M 86.15M 1.09B 88.35M 86.47M 3.77B
Net income 215M 2.95M 2.54M 2.34M 2.2M 4.14M 278M 4.17M 27.71M 10.79M 137M 11.06M 10.83M 472M 96.95M 1.33M 1.15M 1.05M 993K 1.87M 126M 1.88M 12.5M 4.87M 61.6M 4.99M 4.88M 213M
Net Debt 199M 2.73M 2.36M 2.17M 2.04M 3.83M 258M 3.87M 25.68M 10M 127M 10.26M 10.04M 438M 234M 3.22M 2.78M 2.55M 2.4M 4.51M 304M 4.55M 30.23M 11.77M 149M 12.07M 11.81M 515M
Logo INSTITUT
Artgen Biotekh PAO is a Russia-based company engaged in the research and development and invesment in biotechnology. The Company develops and implements drugs, products or methods of treatment, diagnostic and prevention of diseases. The Company invests in assets engaged in development and commercialization of new drugs, medical devices, genetic diagnostics and research and other high-tech products and services related to biomedicine and healthcare. Artgen Biotekh PAO develops a platform for startups and companies to share knowledge related to science, research, production, marketing, business, regulations, patent and other fields. Some of the Company's products are Neovasculgen, a gene therapy drug, vaccines Tetraflubet and Betuvax and others.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!